Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    18946293 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Sugammadex and Neostigmine at Shallow Neuromuscular Blockade
Condition: Neuromuscular Block
Intervention: Drug: Sugammadex, Neostigmine, Saline
2 Not yet recruiting Sugammadex Compared With Neostigmin/Atropin for Neuromuscular Block Reversal in Patients With Obstructive Sleep Apnea
Condition: Obstructive Sleep Apnea
Interventions: Drug: Sugammadex;   Drug: Neostigmine
3 Completed Neuromuscular Blockade Improves Surgical Conditions
Condition: Neuromuscular Blockade
Intervention: Other: Neuromuscular blockade with rocuronium and reversal with sugammadex
4 Completed Sugammadex and Neostigmine at Residual Neuromuscular Blockade
Condition: Residual Neuromuscular Block (TOF-ratio of 0.2)
Interventions: Drug: Sugammadex;   Drug: Neostigmine;   Drug: Saline
5 Completed Comparison of Sugammadex With Neostigmine Administered at 1-2 PTCs After Administration of Rocuronium or Vecuronium (19.4.302)(P05945)(COMPLETED)
Condition: Anesthesia, General
Interventions: Drug: sugammadex;   Drug: neostigmine

Indicates status has not been verified in more than two years